ScholarIQanswers from OpenAlex & ORCID
Michael J. Cork
ResearcherPublications, citations & collaboration network
Michael J. Cork is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael J. Cork have?
ScholarIQindexed works
Michael J. Cork has 392 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael J. Cork have?
ScholarIQcitation count
Michael J. Cork has 23,624 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael J. Cork?
ScholarIQh-index
Michael J. Cork has an h-index of 74 in OpenAlex.
What is the i10-index of Michael J. Cork?
ScholarIQi10-index
Michael J. Cork has an i10-index of 190 in OpenAlex.
What is the ORCID of Michael J. Cork?
ScholarIQorcid
The ORCID for Michael J. Cork is on the source record.
What is the OpenAlex record for Michael J. Cork?
ScholarIQopenalex
The OpenAlex for Michael J. Cork is on the source record.
What are the most-cited papers on Michael J. Cork?
ScholarIQmost cited works
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
Amy Strange, Chris C. A. Spencer, Gavin Band, Céline Bellenguez, Colin L. Freeman, Matti Pirinen, Anna Rautanen, Zhan Su, Peter Donnelly, Francesca Capon, Jo Knight, Michael E. Weale, Michael H. Allen, Christopher G. Mathew, Frank O. Nestlé, Alexandros Onoufriadis, Catherine Smith, Jonathan N Barker, Richard C. Trembath, Anne Barton, Jane Worthington, Judith G.M. Bergboer, Joost Schalkwijk, Patrick L.J.M. Zeeuwen, Jenefer M. Blackwell, Elvira Bramon, Suzannah J. Bumpstead, Panos Deloukas, Sarah Edkins, Emma Gray, Sarah Hunt, Cordelia Langford, Simon Potter, Leena Peltonen, Juan P. Casas, Michael J. Cork, Rachid Tazi‐Ahnini, Aiden Corvin, Alexander Dilthey, Stephen Leslie, Loukas Moutsianas, Gilean McVean, Audrey Duncanson, Xavier Estivill, Eva Riveira‐Muñoz, Oliver FitzGerald, Brian Kirby, Emiliano Giardina, Giuseppe Novelli, Angelika Hofer, Wolfgang Salmhofer, Wolfgang Weger, Ulrike Hüffmeier, André Reis, Alan D. Irvine, Janusz Jankowski, Jesús Lascorz, Joyce Leman, A. David Burden, Lotus Mallbris, Mona Ståhle, Katarina Wolk, Hugh S. Markus, W.H. Irwin McLean, Ross McManus, Anthony W. Ryan, Rotraut Mößner, Åsa Torinsson Naluai, Lena Samuelsson, Colin N A Palmer, Carlo Perricone, R Plomin, Ramón M. Pujol, Stephen Sawcer, Adrian Hayday, Heiko Traupe, Ananth C. Viswanathan, Richard B Warren, Helen Young, Christopher E M Griffiths, Nicholas Wood, Juha Kere, David M. Evans, Matthew A. Brown
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Lam C. Tsoi, Sarah L. Spain, Jo Knight, Eva Ellinghaus, Philip E. Stuart, Francesca Capon, Jun Ding, Yanming Li, Trilokraj Tejasvi, Jóhann E. Guðjónsson, Hyun Min Kang, Michael H. Allen, Ross McManus, Giuseppe Novelli, Lena Samuelsson, Joost Schalkwijk, Mona Ståhle, A. David Burden, Catherine Smith, Michael J. Cork, Xavier Estivill, A. Bowcock, Gerald G. Krueger, Wolfgang Weger, Jane Worthington, Rachid Tazi‐Ahnini, Frank O. Nestlé, Adrian Hayday, Per Hoffmann, Juliane Winkelmann, Cisca Wijmenga, Cordelia Langford, Sarah Edkins, Robert Andrews, Hannah Blackburn, Amy Strange, Gavin Band, Richard D. Pearson, Damjan Vukcevic, Chris C. A. Spencer, Panos Deloukas, Ulrich Mrowietz, Stefan Schreiber, Stephan Weidinger, Sulev Kõks, Külli Kingo, Tõnu Esko, Andres Metspalu, Henry W. Lim, John J. Voorhees, Michael Weichenthal, H.‐Erich Wichmann, Vinod Chandran, Cheryl F. Rosen, Proton Rahman, Dafna D. Gladman, C.E.M. Griffiths, André Reis, Juha Kere, Rajan P. Nair, André Franke, Jonathan N W N Barker, Gonçalo R. Abecasis, James T Elder, Richard C. Trembath
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators
New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene–environment interactions
Michael J. Cork, Darren Robinson, Yiannis Vasilopoulos, Adam Ferguson, Manar Moustafa, Alice MacGowan, Gordon W. Duff, Simon Ward, Rachid Tazi‐Ahnini